Transplant Testing
HLA Pretransplant Workup Sensitized Recipient Panel 4 Test
This test assesses compatibility for kidney and liver transplant recipients, particularly those identified as sensitized. It helps identify potential donor-recipient incompatibilities to improve transplant success.
General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.
Review status: No completed medical review is recorded for this page.
At a glance
Plan your test
- Sample
- 6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube, 9 mL (6 mL min.) serum from 3 SST's, 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube, 4 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube.
- Results
- Confirm with the laboratory before booking.
- Preparation
- Specimens should preferably be collected 48 hours after dialysis. A doctor's prescription on letterhead, along with one photograph each of the recipient and donor (duly stamped), and a consent form for HLA Typing for Solid organ transplant (Form 33) are mandatory. Confirm with the laboratory before booking.
Payment: M-Pesa and card options can be confirmed during booking.
Insurance & government schemes
Is this test covered for you?
We help you verify whether the HLA Pretransplant Workup Sensitized Recipient Panel 4 Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.
Providers & schemes we can help you check
Government & public schemes
Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.
Private insurers & employer schemes
Names shown for identification only — listing does not imply partnership or guarantee of coverage.
Have these ready when we check
- Insurer or scheme name & policy / member number
- A clinician's request / prescription for the test
- Pre-authorisation letter, if your plan requires one
Free coverage check
Ask us to verify your cover
Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.
Start with fit
Is this the right test for you?
The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.
- ✓Individuals awaiting a kidney or liver transplant.
- ✓Patients identified as sensitized recipients.
- ✓Individuals with a history of previous transplants.
- ✓Patients experiencing complications related to organ transplantation.
In plain language
What this test helps you understand
This test measures various components essential for transplant compatibility, including HLA DNA Typing, High resolution NGS, HLA T & B cell lymphocyte crossmatch vs potential donor, HLA Panel Reactive IgG antibodies (PRA) Screen Luminex, and Single antigen bead (SAB) IgG Class I & II Luminex.
Taking this test offers numerous benefits, including identifying compatible donors, reducing the risk of transplant rejection, providing detailed insights into the recipient's immune response, guiding nephrologists in making informed decisions about transplant options, and enhancing the overall success rate of kidney and liver transplants.
Results from the HLA Pretransplant Workup Sensitized Recipient Panel 4 Test will indicate the level of compatibility between the recipient and potential donors. It is crucial to discuss these results with your nephrologist, who will provide guidance on the next steps in the transplant process.
Medical review status
Clinical review pending
A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.
Meet the DNA Labs Kenya medical team →A simple process
What happens next?
You do not have to navigate the test alone. We help you move from question to next step.
Speak with us
We check the test and answer your questions before collection.
Give your sample
Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.
Understand your report
A counselor helps you understand the result and the next steps.
Choose your collection
Home collection or a lab visit
We will explain the sample, preparation, and next steps before anything is collected.
Home collection
Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.
Lab or hub visit
Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.
Ask about locations →Read your report
What common result terms mean
Questions people ask
Frequently asked questions
Collaboration
Open for partnership with hospitals, clinics, doctors & researchers
Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.
Hospitals & clinics
Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.
Doctors & specialists
LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.
Research institutions
Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.
Students & academic projects
Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.
Trust & transparency
Sources, standards & how this page is maintained
Standards & references
- ACMG/AMP technical standards for sequence variant interpretation
- ClinGen curation and gene–disease validity frameworks where applicable
- LOINC-coded reporting for interoperable results
- ISO 9001:2015 quality management; ISO 15189 accreditation in progress
Page provenance
- Last updated: September 27, 2026
- Medical review: not yet completed
- Written for patients & clinicians in Kenya; reviewed periodically against current guidance
Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.
Keep exploring
Related tests
Chimerism Split Cell Analysis T Cell CD3 Test
Monitors post-transplant recovery by measuring the proportion of donor and recipient T cells (CD3 positive) in the blood or bone marrow. Essential for assessing graft acceptance or rejection after hematopoietic stem cell transplantation.
Learn more →HLA ABC Class 1 Typing Test
The HLA ABC Class 1 Typing Test helps determine compatibility between organ donors and recipients, crucial for successful transplantation.
Learn more →HLA AB Class 1 Typing Test
The HLA AB Class 1 Typing Test helps determine compatibility between organ donors and recipients, crucial for successful kidney, liver, or heart transplants. This test identifies specific antigens to minimize organ rejection risk.
Learn more →HLA DP Typing Test
The HLA DP Typing Test helps determine compatibility between organ donors and recipients, crucial for successful transplantation. It assesses specific human leukocyte antigens (HLA) to minimize rejection risk.
Learn more →